Myomo (NYSEAMERICAN:MYO) released its quarterly earnings data on Monday. The company reported ($0.21) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.01), Morningstar.com reports. The business had revenue of $0.61 million during the quarter, compared to analyst estimates of $0.82 million.
NYSEAMERICAN MYO opened at $2.07 on Wednesday. Myomo has a fifty-two week low of $1.60 and a fifty-two week high of $11.40.
Several research firms have weighed in on MYO. Zacks Investment Research upgraded Myomo from a “sell” rating to a “hold” rating in a report on Wednesday, September 12th. HC Wainwright set a $12.00 price objective on Myomo and gave the stock a “buy” rating in a report on Tuesday, August 14th.
A hedge fund recently bought a new stake in Myomo stock. A.R.T. Advisors LLC bought a new position in Myomo Inc (NYSEAMERICAN:MYO) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 93,559 shares of the company’s stock, valued at approximately $277,000. A.R.T. Advisors LLC owned approximately 0.75% of Myomo as of its most recent filing with the SEC.
ILLEGAL ACTIVITY WARNING: “Myomo (MYO) Announces Quarterly Earnings Results, Misses Expectations By $0.01 EPS” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/11/07/myomo-myo-announces-quarterly-earnings-results-misses-expectations-by-0-01-eps.html.
Myomo, Inc, a commercial stage medical robotics company, designs, develops, and produces myoelectric braces or orthotics for people suffering with neuromuscular disorders in the United States. It offers MyoPro, a powered upper limb orthosis that supports the arm, as well as restores function to the weakened or paralyzed arms of patients suffering from CVA stroke, brachial plexus injury, traumatic brain injury, spinal cord injury, ALS, or other neuromuscular disease or injury.
Further Reading: What is the Dow Jones Industrial Average (DJIA)?
Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.